- Clone:
- REA1511 | 29D8
- Type of antibody:
- Recombinant antibodies, Primary antibodies
- Isotype:
- recombinant human IgG1
- Applications:
- MICS, IF, IHC Glossary
- Select a conjugate:
Related products for CD340 (ErbB-2/HER-2) Antibody, anti-human, REAfinity™
Stage0
Stage1
Stage2
Stage3
Clone REA1511 recognizes CD340 (ErbB-2/HER-2), the human receptor tyrosine-protein kinase ErbB-2 antigen, a Single-pass type I membrane protein which is also known as human epidermal growth factor receptor 2 (Her2) or proto-oncogene Neu. CD340 (ErbB-2/HER-2) is a member of the epidermal growth factor receptor family. The ErbB family is composed of four plasma membrane-bound receptor tyrosine kinases. All four contain an extracellular ligand binding domain, a transmembrane domain, and an intracellular domain that can interact with a multitude of signaling molecules and exhibit both ligand-dependent and ligand-independent activity. CD340 (ErbB-2/HER-2) can heterodimerise with any of the other three receptors and is considered to be the preferred dimerisation partner of the other ErbB receptors. Dimerisation results in the autophosphorylation of tyrosine residues within the cytoplasmic domain of the receptors and initiates a variety of signaling pathways. CD340 (ErbB-2/HER-2) has been shown to be involved in embryonic development and cancer progression. Amplification or overexpression of this oncogene has been shown to play an important role in the development and progression of certain aggressive types of cancer. It is an important biomarker and target of therapy for approx. 30% of breast cancer patients.
p185erbB2, HER2, MLN19, MLN 19, NEU, NGL, HER2/neu
Technical specifications
To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.
Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.
- Mileer, D. R. et al. (2019) ErbB-2 signaling in advanced prostate cancer progression and potential therapy. Endocr Relat Cancer 26 (4): R195 doi-R209
- Yamamoto, T. et al. (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319 (6050): 230-234
- Tsutsui, S. et al. (2002) Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol 79 (4): 216-223
- Wang, Y. N. et al. (2012) Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. J. Biol. Chem. 287 (20): 16869-16879
You have previously chosen International as your location.
What do you want to do?